Simple resistance exercise decreases cytokeratin 18 and fibroblast growth factor 21 levels in patients with nonalcoholic fatty liver disease: A retrospective clinical study
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Cytokeratin 18 (CK18) and fibroblast growth factor 21 (FGF21) are elevated in patients with nonalcoholic fatty liver disease (NAFLD) and are useful markers for identifying or monitoring outcomes. Exercise therapy is one of the established treatments for NAFLD; however, few studies have investigated the effectiveness of exercise therapy on CK18 and FGF21 levels. Therefore, the aim of the present study was to assess the effects of 12 weeks of simple resistance exercise on CK18 and FGF21 levels in patients with NAFLD. Fifty patients with NAFLD were assigned to a resistance exercise group (n = 23) or a control group (n = 27) for a trial period of 12 weeks. During the study, the resistance exercise group performed two exercises (push-ups and squats) three times a week on nonconsecutive days, whereas the control group proceeded with regular physical activities under a restricted diet. We then compared serum levels of CK18 fragments (M65) and FGF21 between groups just before and after the 12-week period. Serum M65 levels (880.0 ± 503.6 vs 648.9 ± 450.2 U/L; P < .01) were significantly decreased in the exercise group. However, no significant differences were observed in body mass index or skeletal muscle. The decreases in serum M65 (−231.1 ± 354.7 vs 56.2 ± 375.0 U/L; P = .02), and FGF21 levels (−41.7 ± 98.2 vs. 33.2 ± 127.6 pg/mL; P = .03) were significantly greater in the exercise than in the control group. Changes in M65 levels in the exercise group were significantly correlated with changes in alanine aminotransferase levels (r = 0.618, P < .01). Simple resistance exercise reduced CK18 and FGF21 levels in patients with NAFLD. These findings suggest that resistance exercise consisting of push-ups and squats helps prevent the progression of NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: a systematic review
Hashida, R., Kawaguchi, T., Bekki, M., Omoto, M., Matsuse, H., Nago, T., Takano, Y., Ueno, T., Koga, H., George, J., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.023 · Cited by 509 · cited 2×
“Aerobic and resistance exercises both improve liver fat and transaminase in patients with NAFLD.([4]) However, only one study reported that aerobic exercise reduced the levels of CK18 in patients with NAFLD.”
BackgroundFGF21 is an Akt‐regulated myokine
Izumiya, Y., Bina, H. A., Ouchi, N., Akasaki, Y., Kharitonenkov, A., & Walsh, K. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.10.021 · Cited by 415 · cited 2×
“FGF21 is upregulated by insulin based on activation of the PI3K/Akt signaling pathway in skeletal muscle.([18,22]) Therefore, improvements in insulin sensitivity by resistance training can be related to decreased serum FGF21 levels at rest.”
BackgroundTimmerman, K. L., Flynn, M. G., Coen, P. M., Markofski, M. M., & Pence, B. D. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0408244 · Cited by 324
Fibroblast Growth Factor-21 Is Induced in Human Skeletal Muscles by Hyperinsulinemia
Hojman, P., Pedersen, M., Nielsen, A. R., Krogh-Madsen, R., Yfanti, C., Åkerstrom, T., Nielsen, S., & Pedersen, B. K. (2009) · Diabetes · doi:10.2337/db09-0713 · Cited by 198
Exercise increases serum fibroblast growth factor 21 (FGF21) levels
Cuevas-Ramos, D., Almeda-Valdés, P., Meza-Arana, C. E., Brito-Córdova, G., Gómez-Pérez, F. J., Mehta, R., Oseguera-Moguel, J., & Aguilar-Salinas, C. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038022 · Cited by 178 · cited 1×
“In contrast to our findings in the present study, exercise increased serum FGF21 levels.([20,21]) This difference can be explained by several factors.”
Fibroblast growth factor 21: a regulator of metabolic disease and health span
Xie, T., & Leung, P. S. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00101.2017 · Cited by 121 · cited 1×
“FGF21 is produced by not only hepatocytes but also muscle cells, and it regulates glucose and lipid metabolism.([18,19]) FGF21 levels are elevated in NAFLD and in obesity, metabolic syndrome, and type 2 diabetes.”
BackgroundShort-term exercise reduces markers of hepatocyte apoptosis in nonalcoholic fatty liver disease
Fealy, C. E., Haus, J. M., Solomon, T. P. J., Pagadala, M., Flask, C. A., McCullough, A. J., & Kirwan, J. P. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00127.2012 · Cited by 102 · cited 2×
“A previous study reported that short-term exercise reduced serum CK18 (M30) in patients with NAFLD.([5]) The authors speculated that the lipotoxicity reduction by exercise reduced the proapoptotic stimulus given to hepatocytes result due to a significant correlation between circulating soluble Fas ligand and changes in”
BackgroundSimple resistance exercise helps patients with non-alcoholic fatty liver disease
Takahashi, A., Abe, K., Usami, K., Imaizumi, H., Hayashi, M., Okai, K., Kanno, Y., Tanji, N., Watanabe, H., & Ohira, H. (2015) · International Journal of Sports Medicine · doi:10.1055/s-0035-1549853 · Cited by 53 · cited 4×
“We recently reported that simple resistance exercises improve the characteristics of metabolic syndrome, including ALT, in patients with NAFLD.([7]) Exercise therapy is an established treatment in NAFLD regardless of exercise type, such as aerobic or resistance;”
BackgroundMethodInfluentialSelf-citation
Cited by
Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
Rong, L., Zou, J., Ran, W., Qi, X., Chen, Y., Cui, H., & Guo, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1087260 · Cited by 301
Exercise Is Medicine for Nonalcoholic Fatty Liver Disease: Exploration of Putative Mechanisms
Heinle, J. W., DiJoseph, K., Sabag, A., Oh, S., Kimball, S. R., Keating, S., & Stine, J. G. (2023) · Nutrients · doi:10.3390/nu15112452 · Cited by 26
“[47] found that after 12 weeks of resistance training in which participants performed push-ups and squats three times a week on non-consecutive days, serum FGF-21 level was significantly reduced, confirming the results seen with aerobic exercise training in animal models of NAFLD.”
ResultObesity and Exercise: New Insights and Perspectives
James, N. M., & Stanford, K. I. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf017 · Cited by 20
Astinchap, A., Monazzami, A., Fereidoonfara, K., Rahimi, Z., & Rahimi, M. (2021) · Hepatitis Monthly · doi:10.5812/hepatmon.116513 · Cited by 15
“In fact, NAFLD creates a state of resistance to FGF-21, which causes the level of serum FGF-21 to be different in healthy people and this group of patients (5).”
BackgroundResultInfluentialThe effects of exercise on FGF21 in adults: a systematic review and meta-analysis
Liu, C., Yan, X., Zong, Y., He, Y., Yang, G., Xiao, Y., & Wang, S. (2024) · PeerJ · doi:10.7717/peerj.17615 · Cited by 14
Metadata
- Authors
- Takahashi, A., Abe, K., Fujita, M., Hayashi, M., Okai, K., & Ohira, H.
- Venue
- Medicine
- Published
- 2020-05-29
- Volume
- 99
- Issue
- 22
- Pages
- e20399
- ISSN
- 0025-7974 (ISSN-L)
- 1536-5964
- OpenAlex
- W3031288930
- Cited by
- 32
- References
- 8
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Simple resistance exercise decreases cytokeratin 18 and fibroblast growth factor 21 levels in patients with nonalcoholic fatty liver disease: A retrospective clinical study. https://app.cochat.ai/papers/10.1097/md.0000000000020399
- The paper
- Takahashi, A., Abe, K., Fujita, M., Hayashi, M., Okai, K., & Ohira, H. (2020). Simple resistance exercise decreases cytokeratin 18 and fibroblast growth factor 21 levels in patients with nonalcoholic fatty liver disease: A retrospective clinical study. Medicine. https://doi.org/10.1097/md.0000000000020399
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.